Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RPRX

Royalty Pharma (RPRX)

Royalty Pharma PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RPRX
DateTimeSourceHeadlineSymbolCompany
11/01/202509:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:RPRXRoyalty Pharma PLC
11/01/202509:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
10/01/202523:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
10/01/202523:30GlobeNewswire Inc.Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RPRXRoyalty Pharma PLC
10/01/202523:15GlobeNewswire Inc.Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase ProgramNASDAQ:RPRXRoyalty Pharma PLC
10/01/202508:15GlobeNewswire Inc.Royalty Pharma Announces Dividend IncreaseNASDAQ:RPRXRoyalty Pharma PLC
01/01/202508:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
28/11/202408:15GlobeNewswire Inc.Royalty Pharma to Present at Upcoming Investor ConferencesNASDAQ:RPRXRoyalty Pharma PLC
15/11/202408:30GlobeNewswire Inc.Royalty Pharma Announces Inaugural Prize for Impact in HealthcareNASDAQ:RPRXRoyalty Pharma PLC
07/11/202423:10GlobeNewswire Inc.Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 MillionNASDAQ:RPRXRoyalty Pharma PLC
07/11/202401:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPRXRoyalty Pharma PLC
06/11/202423:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
06/11/202423:15GlobeNewswire Inc.Royalty Pharma Reports Third Quarter 2024 ResultsNASDAQ:RPRXRoyalty Pharma PLC
05/11/202408:15GlobeNewswire Inc.Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for NiktimvoNASDAQ:RPRXRoyalty Pharma PLC
05/11/202408:01PR Newswire (US)Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™NASDAQ:RPRXRoyalty Pharma PLC
17/10/202407:15GlobeNewswire Inc.Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:RPRXRoyalty Pharma PLC
11/10/202423:15GlobeNewswire Inc.Royalty Pharma Declares Fourth Quarter 2024 DividendNASDAQ:RPRXRoyalty Pharma PLC
27/09/202422:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
04/09/202407:14GlobeNewswire Inc.Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding AgreementNASDAQ:RPRXRoyalty Pharma PLC
04/09/202407:06GlobeNewswire Inc.Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding AgreementNASDAQ:RPRXRoyalty Pharma PLC
29/08/202406:15GlobeNewswire Inc.Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare ConferenceNASDAQ:RPRXRoyalty Pharma PLC
13/08/202409:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
13/08/202409:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
13/08/202409:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RPRXRoyalty Pharma PLC
08/08/202423:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RPRXRoyalty Pharma PLC
08/08/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
08/08/202421:00GlobeNewswire Inc.Royalty Pharma Reports Second Quarter 2024 ResultsNASDAQ:RPRXRoyalty Pharma PLC
07/08/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RPRXRoyalty Pharma PLC
30/07/202406:30Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:RPRXRoyalty Pharma PLC
24/07/202422:30GlobeNewswire Inc.Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human CapitalNASDAQ:RPRXRoyalty Pharma PLC
 Showing the most relevant articles for your search:NASDAQ:RPRX